UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research

Vaccine, 2021-06, Vol.39 (28), p.3678-3695

2021

Volltextzugriff (PDF)

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11

Vaccine, 2016-02, Vol.34 (7), p.981-988

2016

Volltextzugriff (PDF)

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses

Antiviral research, 2016-05, Vol.129, p.21-38

2016

Volltextzugriff (PDF)

Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14

Vaccine, 2015-06, Vol.33 (26), p.3003-3009

2015

Volltextzugriff (PDF)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017

Antiviral research, 2018-09, Vol.157, p.38-46

2018

Volltextzugriff (PDF)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016

Antiviral research, 2017-10, Vol.146, p.12-20

2017

Volltextzugriff (PDF)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

Antiviral research, 2015-05, Vol.117, p.27-38

2015

Volltextzugriff (PDF)

Respiratory syncytial virus hospitalization in middle-aged and older adults

Journal of clinical virology, 2017-11, Vol.96, p.37-43

2017

Volltextzugriff (PDF)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015

Antiviral research, 2016-08, Vol.132, p.178-185

2016

Volltextzugriff (PDF)

Hospitalizations Attributable to Respiratory Infections among Children with Neurologic Disorders

The Journal of pediatrics, 2016-03, Vol.170, p.135-141.e5

2016

Volltextzugriff (PDF)

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19

Vaccine, 2020-09, Vol.38 (42), p.6562-6569

2020

Volltextzugriff (PDF)

Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children – A systematic review and a meta-analysis

Vaccine, 2020-01, Vol.38 (3), p.608-619

2020

Volltextzugriff (PDF)

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012–2016

Vaccine, 2018-12, Vol.36 (52), p.8047-8053

2018

Volltextzugriff (PDF)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013

Antiviral research, 2014-10, Vol.110, p.31-41

2014

Volltextzugriff (PDF)

Hospitalizations within 14 days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012

Vaccine, 2017-01, Vol.35 (4), p.529-535

2017

Volltextzugriff (PDF)

Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012

Vaccine, 2017-01, Vol.35 (4), p.529-535

2017

Volltextzugriff (PDF)

Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh

Vaccine, 2017-12, Vol.35 (50), p.6967-6976

2017

Volltextzugriff (PDF)

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses

Antiviral research, 2009, Vol.81 (1), p.16-24

2009

Volltextzugriff (PDF)

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States

Antiviral research, 2012-03, Vol.93 (3), p.381-386

2012

Volltextzugriff (PDF)

A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study

Vaccine, 2011-06, Vol.29 (26), p.4416-4421

2011

Volltextzugriff (PDF)

First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

The Lancet (British edition), 2020-04, Vol.395 (10230), p.1137-1144

2020

Volltextzugriff (PDF)

Influenza antiviral prescribing practices during the 2007–08 and 2008–09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses

Antiviral research, 2010-11, Vol.88 (2), p.182-186

2010

Volltextzugriff (PDF)

Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly

Vaccine, 2002-12, Vol.21 (3), p.303-311

2002

Volltextzugriff (PDF)

Letter in response to commentary by Small and Cronin

Vaccine, 2017-09, Vol.35 (39), p.5225-5225

2017

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(22)
Influenza
(17)
Female
(12)
Immunology
(12)
Medicine, Research & Experimental
(12)
Research & Experimental Medicine
(12)
Vaccines
(12)
Virology
(11)
Pharmacology & Pharmacy
(10)
Male
(9)
Child
(8)
Antiviral Agents - Pharmacology
(7)
Child, Preschool
(7)
Immunization
(7)
Influenza, Human - Prevention & Control
(7)
Influenza, Human - Virology
(7)
Biological And Medical Sciences
(6)
Children
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses

Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

Respiratory syncytial virus hospitalization in middle-aged and older adults

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015

Hospitalizations Attributable to Respiratory Infections among Children with Neurologic Disorders

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19

Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children – A systematic review and a meta-analysis

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012–2016

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013

Hospitalizations within 14 days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012

Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012

Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh

A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0–9 years of age hospitalized with influenza in El Salvador and Panama

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States

A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study

First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

Influenza antiviral prescribing practices during the 2007–08 and 2008–09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses

Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly

Letter in response to commentary by Small and Cronin

Aktive Filter

Suchergebnisse filtern